Blau Farmaceutica SA (BLAU3) Stock Statistics & Valuation Metrics

Blau Farmaceutica SA has a market cap or net worth of R$2.01B. The enterprise value is $2.35K.

Blau Farmaceutica SA has 233,212,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

Blau Farmaceutica SA’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 7.99%.

The current PE Ratio of Blau Farmaceutica SA is 6.9. Blau Farmaceutica SA’s PEG ratio is -0.56.

In the last 12 months, Blau Farmaceutica SA had revenue of 1.70B and earned 294.95M in profits. Earnings per share was 0.98.

In the last 12 months, operating cash flow was 237.71M and capital expenditures -374.55M, giving a free cash flow of -136.84M billion.

Blau Farmaceutica SA pays an annual dividend of ―, resulting in a dividend yield of ―

Blau Farmaceutica SA upcoming earnings date is Aug 11, 2026, TBA (Confirmed).

Blau Farmaceutica SA as a current ratio of 2.47, with Debt / Equity ratio of 24.43%

In the past 12 months, Blau Farmaceutica SA has paid 91.70M in taxes.

Blau Farmaceutica SA EV to EBITDA ratio is 9.64, with an EV/FCF ratio of -95.47.

Blau Farmaceutica SA has R$542.18M in cash and marketable securities with R$560.29M in debt, giving a net cash position of -R$18.10M billion.

Gross margin is 39.41%, with operating margin of 19.37%, and net profit margin of 17.33%.

The average price target for Blau Farmaceutica SA is ―, which is 11.43% higher than the current price. The consensus rating is ―